Mealey's (October 4, 2022, 10:53 AM EDT) -- NEW YORK — A New York federal judge denied a motion by two drug makers to decertify an antitrust class action for indirect purchasers of the Alzheimer’s drug Namenda (memantine) ahead of an Oct. 19 trial....